As VEGF-C is essential for the development of the lymphatic vasculature, it has also been found to be involved in tumor-induced angiogenesis by binding to its receptor, VEGFR3, which can be highly expressed in vascular endothelial cells of tumor-bearing tissues [96,97,98]. Here, VEGFC is linked to neoplasm.